|Bid||34.79 x 1100|
|Ask||46.66 x 1200|
|Day's Range||34.45 - 37.13|
|52 Week Range||19.46 - 48.07|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.60|
Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2020 on Tuesday, Nov. 3 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.
Avanos Medical, Inc. (NYSE: AVNS) today announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer.